• Have a question?
    Open from 8am to 7pm Monday to Friday
    Call customer services
    0345 54 32 600

AXA Framlington Health Fund Z Acc

Healthcare and Biotechnology
Price: 508.30p|Change: 2.10 (0.41%)

Pricing frequency 

Daily


Dealing cut off time 

11:00


Type 

Unit Trust


Yield 

0.12%


NAV 

508.30p


Income frequency 

Semi-annually


Ongoing charge 

0.82%


Latest actual NAV date 

16-11-2026


ISIN 

GB00B6WZJX05


UCITS 

Yes


Growth of 10k

Asset allocation

Top 10 holdings

Holdings 31/10/2026% of assets
Eli Lilly and Co9.08
Thermo Fisher Scientific Inc5.57
UnitedHealth Group Inc4.77
Teva Pharmaceutical Industries Ltd4.32
Natera Inc4.00
Novartis AG Registered Shares3.95
Roche Holding AG Ordinary Shares new3.89
AbbVie Inc3.89
AstraZeneca PLC3.26
Danaher Corp3.08

Performance 31/10/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Fund+ 0.41
Category-
More...

Investment objective

The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.

Morningstar ratingTM


Morningstar sustainability ratingTM


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.